Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma.
about
Indole-3-carbinol inhibits nasopharyngeal carcinoma growth through cell cycle arrest in vivo and in vitroPrognostic value of parotid lymph node metastasis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapyPromoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells.Open-label, single-arm phase II study of pemetrexed in the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma who have had prior platinum-based chemotherapy.Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinomaMulti-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens.Anti-tumor effect of oncolytic herpes simplex virus G47delta on human nasopharyngeal carcinoma.Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways.Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis.Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5 year follow-upExpression of human leukocyte antigen G is associated with prognosis in nasopharyngeal carcinoma.Upregulated Expression of SOX4 Is Associated with Tumor Growth and Metastasis in Nasopharyngeal Carcinoma.Pretreatment Serum Lactate Dehydrogenase and N Classification Predict Long-Term Survival and Distant Metastasis in Patients With Nasopharyngeal Carcinoma Who Have A Positive Family History of Cancer.Functional elucidation of miR-494 in the tumorigenesis of nasopharyngeal carcinoma.Expression of heat shock protein 70 in nasopharyngeal carcinomas: different expression patterns correlate with distinct clinical prognosisTargeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma.Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled studyCombining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngealPhase II study of gemcitabine plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy.Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis.Suppressing tumor growth of nasopharyngeal carcinoma by hTERTC27 polypeptide delivered through adeno-associated virus plus adenovirus vector cocktail.PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survivalNasopharyngeal carcinoma in adults: treatment results after long-term follow-up with special reference to adjuvant interferon-beta in undifferentiated carcinomas.CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling.BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.Oncogene mutational profile in nasopharyngeal carcinoma.Parotid gland metastasis of nasopharyngeal carcinoma: case report and review of the literature.Definitive treatment of metastatic nasopharyngeal carcinoma: Report of 5 cases with review of literature.Knockdown of c-Myc inhibits cell proliferation by negatively regulating the Cdk/Rb/E2F pathway in nasopharyngeal carcinoma cells.Silencing of c-Met by RNA interference inhibits the survival, proliferation, and invasion of nasopharyngeal carcinoma cells.Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility studyComplete small bowel obstruction caused by metastasis from primary nasopharyngeal carcinoma.Improvement in quality of life in patients with nasopharyngeal carcinoma treated with non-invasive extracorporeal radiofrequency in combination with chemoradiotherapy.Endostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an Update.Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma.Lack of association between let-7 binding site polymorphism rs712 and risk of nasopharyngeal carcinoma.Enhancing the immune stimulatory effects of cetuximab therapy through TLR3 signalling in Epstein-Barr virus (EBV) positive nasopharyngeal carcinoma
P2860
Q28537579-941BC54A-50BF-4D9D-9D7A-9A5BDBCF9843Q30402930-11BA0139-EF2B-4864-BB34-2B302A8CBAEAQ33367808-69D27146-0948-4B21-9818-62450C23FF95Q33402865-63F88D2D-1D8E-4FD8-91CB-F832F7F00225Q33428455-B02DBE27-B36D-4A85-B4B2-ACE8C1C41DABQ33439361-6DE7D22F-54AE-47B1-A1D7-604950435D29Q33579396-736CF514-812D-43C7-BC7B-07A8AE451524Q33638975-1F473E35-F78D-4D27-ABFF-872CB90F8C57Q34074410-AB791861-8F5C-430C-B085-011D7BCCD944Q34492567-77B15704-4F3C-4CAE-B9A6-B187C288A07DQ36063731-4313ADAD-57B3-4BA2-B2FE-2906F714D3FAQ36249545-AE81C3CF-862A-4EB5-9F69-B8914DC0DBE6Q36256111-67136200-1CC5-48C0-A7D6-A76226C16ED1Q36278144-9C080CC7-6277-40DF-AE57-5DD98123581EQ36338606-E4503BB2-E4C7-4698-A2DA-1030E7D6C352Q36413665-FB170549-DF9D-42AD-A430-2BB2B2F715B1Q36439727-22D94A17-89DA-4C1B-B7EC-49DC19AD3826Q36546040-967E5191-AA87-4BEF-A8CF-AD9150ACD539Q36915011-8BD22F51-640F-4A2B-AF0C-FD1E6CBE5B30Q36940726-6BB955A8-4D62-4B13-9622-378D58F4C15AQ37183614-9308EB9E-A6D0-4A60-A3B7-0F42A9D0E8DDQ37295736-64A681EB-58EC-4EB8-98FC-49AAD57DCB30Q37425889-098E7F99-6AEC-4DFD-951B-2B5451DA40D1Q37611019-6BC54393-116D-4625-986E-C4319CBD3DD6Q37648125-89A89958-F046-47CA-834D-5227E69CA6D5Q37660226-3C5BE6E0-A633-43D5-B9D7-74E62C1C9687Q37690445-415CFA57-56DF-4245-AA51-D78A3B14B646Q38001385-B51FC6B9-7A43-4235-A8CA-7E2BB55C8191Q38915636-0D8192EA-160F-4591-ADB1-E69F80EF85B9Q39472980-FA59B2AE-8F07-4A66-9A59-5F1D840EC776Q41195176-EAD83D0B-344C-4DD4-AA0F-1BB0CFEC4EADQ41389660-7DB0B91F-BB5C-4511-9FC3-5CCFC968E1E2Q45953770-B1FAB43D-F659-413F-AB24-C0590BFD035CQ50137405-8F65A922-C2F1-4BE8-B335-50867CF981A4Q53700212-58B2EA1F-1669-4E30-BBF4-188F3DB20A44Q54245253-F7EC8F3F-34D8-463C-9E01-663176CBF357Q58129526-DE3740A6-583E-47F8-92B3-32DDD4D3C442
P2860
Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Recent perspectives in the rol ...... nced nasopharyngeal carcinoma.
@ast
Recent perspectives in the rol ...... nced nasopharyngeal carcinoma.
@en
type
label
Recent perspectives in the rol ...... nced nasopharyngeal carcinoma.
@ast
Recent perspectives in the rol ...... nced nasopharyngeal carcinoma.
@en
prefLabel
Recent perspectives in the rol ...... nced nasopharyngeal carcinoma.
@ast
Recent perspectives in the rol ...... nced nasopharyngeal carcinoma.
@en
P356
P1433
P1476
Recent perspectives in the rol ...... nced nasopharyngeal carcinoma.
@en
P2093
Anthony T C Chan
Brigette B Y Ma
P356
10.1002/CNCR.20768
P407
P577
2005-01-01T00:00:00Z